本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2001/8/61 分钟阅读
Mylan Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 66 Abbreviated New Drug Applications
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is withdrawing approval of 66 abbreviated new drug applications (ANDAs). The holders of the applications notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →